NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS (Tables)

12 Months Ended

Dec. 31, 2021

Earnings Per Share [Abstract]

SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED

The following tables present reconciliations for the numerators and denominators of basic and diluted net loss per share:

	For the Year Ended December 31,
Numerator:	2021			2020
Net loss, primary	$	(30,187	)	$	(42,854	)
Gain from change in fair value of warrant liabilities		–			2,914
Net loss, diluted	$	(30,187	)	$	(45,768	)

	For the Year Ended December 31,
Denominator:	2021		2020
Basic weighted average number of common shares(1)		80,014,014		38,779,316
Potentially dilutive effect of warrants		–		588,074
Diluted weighted average number of common shares		80,014,014		39,367,390

(1)  In December 2020 and January 2021, the Company sold pre-funded warrants to purchase up to 5,238,043 and 2,420,910 shares of common stock, respectively. The shares of common stock associated with the pre-funded warrants are considered outstanding for the purposes of computing earnings per share prior to exercise because the shares may be issued for little or no consideration, are fully vested, and are exercisable after the original issuance date. The pre-funded warrants sold in December 2020 and January 2021 were exercised in January 2021and included in the denominator for the period of time the warrants were outstanding.

SCHEDULE OF ANTI-DILUTIVE POTENTIAL SHARES OUTSTANDING ACTIVITY

The following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share for the periods presented due to their anti-dilutive effect:

	For the Year Ended December 31,
	2021		2020
Stock options		5,772,802		4,794,567
Restricted stock		5,163,685		3,468,969
Common stock warrants		19,314,143		–